Men and women, so different, so similar: Observations from cross-sex hormone treatment of transsexual subjects

Andrologia

Volumn 46, Issue 5, 2014, Pages 570-575

  Gooren, L J ^a,c   Giltay, E J ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Androconsult   (Thailand)

Author keywords

Oestrogen; Sex difference; Testosterone; Transsexual

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE PLUS ETHINYLESTRADIOL; ESTROGEN; SEX HORMONE; TESTOSTERONE;

ARTICLE; AUTOIMMUNE DISEASE; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; FEMALE; FEMALE TO MALE TRANSSEXUAL; FRACTURE; GENDER IDENTITY; HORMONAL THERAPY; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; MALE; MALE TO FEMALE TRANSSEXUAL; SEX DIFFERENCE; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT; TRANSSEXUALITY; X CHROMOSOME; Y CHROMOSOME; HORMONE SUBSTITUTION; TRANSSEXUALISM;

FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; TRANSSEXUALISM;

EID: 84899627167     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/and.12111     Document Type: Article

References (29)

1. Bentvelsen FM, Brinkmann AO, van der Schoot P, van der Linden JE, van der Kwast TH, Boersma WJ, Schroder FH, Nijman JM (1995) Developmental pattern and regulation by androgens of androgen receptor expression in the urogenital tract of the rat. Mol Cell Endocrinol 113:245-253.
2. Bunck MC, Giltay EJ, Diamant M, Gooren LJ, Teerlink T (2009) Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals. Atherosclerosis 206:245-250.
3. Elbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ (1997) Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab 82:2044-2047.
4. Elbers JM, de Jong S, Teerlink T, Asscheman H, Seidell JC, Gooren LJ (1999) Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Metabolism 48:1371-1377.
5. Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, Gooren LJ (2003) Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 58:562-571.
6. Giltay EJ, Gooren LJ (2000) Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 85:2913-2921.
7. Giltay EJ, Elbers JM, Gooren LJ, Emeis JJ, Kooistra T, Asscheman H, Stehouwer CD (1998a) Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol 18:1716-1722.
8. Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD (1998b) Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 83:550-553.
9. Giltay EJ, Lambert J, Gooren LJ, Elbers JM, Steyn M, Stehouwer CD (1999) Sex steroids, insulin, and arterial stiffness in women and Men. Hypertension 34:590-597.
10. Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ (2000) In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 85:1648-1657.
11. Giltay EJ, Verhoef P, Gooren LJ, Geleijnse JM, Schouten EG, Stehouwer CD (2003) Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals. Atherosclerosis 168:139-146.
12. Giltay EJ, Kho KH, Blansjaar BA, Verbeek MM, Geurtz PB, Geleijnse JM, Gooren LJ (2005) The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects. J Endocrinol 187:109-116.
13. Gooren L (2006) The biology of human psychosexual differentiation. Horm Behav 50:589-601.
14. Inoubli A, De Cuypere G, Rubens R, Heylens G, Elaut E, Van Caenegem E, Menten B, T'Sjoen G (2011) Karyotyping, is it worthwhile in transsexualism? J Sex Med 8:475-478.
15. Lips P, Asscheman H, Uitewaal P, Netelenbos JC, Gooren L (1989) The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res 4:657-662.
16. Lombardo F, Toselli L, Grassetti D, Paoli D, Masciandaro P, Valentini F, Lenzi A, Gandini L (2013) Hormone and genetic study in male to female transsexual patients. J Endocrinol Invest 36:550-557.
17. Ngun TC, Ghahramani N, Sanchez FJ, Bocklandt S, Vilain E (2011) The genetics of sex differences in brain and behavior. Front Neuroendocrinol 32:227-246.
18. Polderman KH, Gooren LJ, Asscheman H, Bakker A, Heine RJ (1994) Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79:265-271.
19. Savic I, Garcia-Falgueras A, Swaab DF (2010) Sexual differentiation of the human brain in relation to gender identity and sexual orientation. Prog Brain Res 186:41-62.
20. Slabbekoorn D, van Goozen SH, Megens J, Gooren LJ, Cohen-Kettenis PT (1999) Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology 24:423-447.
21. Slagter MH, Gooren LJ, Scorilas A, Petraki CD, Diamandis EP (2006) Effects of long-term androgen administration on breast tissue of female-to-male transsexuals. J Histochem Cytochem 54:905-910.
22. Sommer IE, Cohen-Kettenis PT, van Raalten T, Vd Veer AJ, Ramsey LE, Gooren LJ, Kahn RS, Ramsey NF (2008) Effects of cross-sex hormones on cerebral activation during language and mental rotation: an fMRI study in transsexuals. Eur Neuropsychopharmacol 18:215-221.
23. Toorians AW, Thomassen MC, Zweegman S, Magdeleyns EJ, Tans G, Gooren LJ, Rosing J (2003) Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 88:5723-5729.
24. Van Goozen SH, Cohen-Kettenis PT, Gooren LJ, Frijda NH, Van de Poll NE (1994) Activating effects of androgens on cognitive performance: causal evidence in a group of female-to-male transsexuals. Neuropsychologia 32:1153-1157.
25. Van Goozen SH, Cohen-Kettenis PT, Gooren LJ, Frijda NH, Van de Poll NE (1995) Gender differences in behaviour: activating effects of cross-sex hormones. Psychoneuroendocrinology 20:343-363.
26. Van Kesteren P, Meinhardt W, van der Valk P, Geldof A, Megens J, Gooren L (1996) Effects of estrogens only on the prostates of aging men. J Urol 156:1349-1353.
27. Van Kesteren P, Lips P, Gooren LJ, Asscheman H, Megens J (1998a) Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol (Oxf) 48:347-354.
28. Van Kesteren PJ, Kooistra T, Lansink M, van Kamp GJ, Asscheman H, Gooren LJ, Emeis JJ, Vischer UM, Stehouwer CD (1998b) The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost 79:1029-1033.
29. Yin Y, Lin C, Ma L (2006) MSX2 promotes vaginal epithelial differentiation and wolffian duct regression and dampens the vaginal response to diethylstilbestrol. Mol Endocrinol 20:1535-1546.